Patients Reactions Towards Their Diagnosis as Having COVI... | NCT04581928

Studies
Patients Reactions Towards Their Diagnosis as Having COVID-19

NCT04581928

Sponsor

ClinAmygate

Status

Unknown status

Last Update Posted

Sep 6, 2023Actual

Enrollment

3,812Estimated

Phase

Not provided

Conditions

Covid19

Interventions

Not provided

Countries

Egypt

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Sep 2023

Overall Recruitment Status or Expanded Access Status

Unknown status

Last Known Status

Recruiting

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Oct 10, 2020Actual

Primary Completion Date

Oct 10, 2023Estimated

Completion Date

Dec 30, 2023Estimated

First Submitted Date

Oct 6, 2020

First Submission Date that Met QC Criteria

Oct 8, 2020

First Posted Date

Oct 9, 2020Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Sep 4, 2023

Last Update Posted Date

Sep 6, 2023Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

Patients reactions towards their diagnosis as having COVID-19. The effect of patients' reaction toward their prospect management. How this can make many hazards. Also, obstacle and barrier to better management.

Detailed Description

Different factors affecting the response of people toward their diagnosis as COVID-19

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

3,812Estimated

Label	Type	Description	Intervention Names
COVID-19		Highly educated people Low educated people

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Time to recovery	Time needed to recovery from symptoms of covid-19	Four weeks

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

COVID-19
Age 18 years of less

Exclusion Criteria:

Mental diseases making the communication with them difficult

Accepts Healthy Volunteers

Not provided

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

Not provided

Standard Ages

AdultOlder Adult

Study Population

All COVID-19 cases

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Emad R Issak, MD	Contact	01272228989		dr.emad.r.h.issak@gmail.com

Overall Officials

Name	Affiliation	Role
Emad R Issak, MD	Assalam Clinics	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
Asalam	Recruiting	Maadi	Cairo Governorate	11433	Egypt

References Module

Citations

PubMed Identifier	Type	Citation	Retractions
7769754	Result	Wiseman EJ. Denial in the medical interview. JAMA. 1995 Jun 14;273(22):1735; author reply 1735-6. doi: 10.1001/jama.273.22.1735. No abstract available.

ID	Term
D011024	Pneumonia, Viral
D011014	Pneumonia
D012141	Respiratory Tract Infections
D007239	Infections